Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant
- PMID: 19364305
Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant
Abstract
Objectives: The forkhead box P3 (FOXP3) gene is considered to be the master gene of regulatory T cells. The significance of regulatory T cells in liver transplant has been investigated in previous reports, but quantitative FOXP3 messenger RNA (mRNA) expression after living-donor liver transplant has not been assessed. The objective of this study was to determine whether the human FOXP3 gene is a good marker for regulatory activity in T cells in living-donor liver transplant recipients during the immediate posttransplant period.
Materials and methods: In peripheral blood mononuclear cells of 15 living-donor liver transplant recipients during the first month after transplant; we measured the population of CD4+CD25+ T cells using flow-assisted cell sorting and the expression of FOXP3 mRNA using real-time polymerase chain reaction.
Results: Fold induction of FOXP3 mRNA significantly increased on postoperative day 7 (3.3-fold) compared with the reference preoperative value (P < .01) but returned to baseline by 28 days after transplant. The population of CD4+CD25+ T cells did not change significantly. Expression of FOXP3 mRNA on days 14, 21, and 28 were lower in recipients with acute cellular rejection within 60 days after living-donor liver transplant.
Conclusions: Increased expression of FOXP3 mRNA immediately after living-donor liver transplant might be influenced by activation of T cells including regulatory T cells and other T cells. However, after stabilization of these activation profiles, it seems likely that FOXP3mRNA expression is associated with graft acceptance. Further studies are necessary with measurement of FOXP3 mRNA expression at appropriate sampling points.
Similar articles
-
FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.Transplantation. 2008 Nov 27;86(10):1370-8. doi: 10.1097/TP.0b013e318188d3e6. Transplantation. 2008. PMID: 19034005
-
The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients.Transplantation. 2008 Dec 27;86(12):1837-43. doi: 10.1097/TP.0b013e31818febc4. Transplantation. 2008. PMID: 19104431
-
Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.Transpl Immunol. 2008 Apr;19(1):69-73. doi: 10.1016/j.trim.2008.01.005. Epub 2008 Feb 22. Transpl Immunol. 2008. PMID: 18346640 Clinical Trial.
-
Foxp3 as a marker of tolerance induction versus rejection.Curr Opin Organ Transplant. 2009 Feb;14(1):40-5. doi: 10.1097/MOT.0b013e32831da83c. Curr Opin Organ Transplant. 2009. PMID: 19337145 Review.
-
Diagnostic value of regulatory T cells: a new facet of a much studied cell population.Transplantation. 2008 Dec 15;86(11):1485-91. doi: 10.1097/TP.0b013e31818f3d2a. Transplantation. 2008. PMID: 19077879 Review.
Cited by
-
Untangling the Knots of Regulatory T Cell Therapy in Solid Organ Transplantation.Front Immunol. 2022 Jun 1;13:883855. doi: 10.3389/fimmu.2022.883855. eCollection 2022. Front Immunol. 2022. PMID: 35720387 Free PMC article. Review.
-
The imbalance of T helper 17/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression.Immunology. 2013 Feb;138(2):124-33. doi: 10.1111/imm.12021. Immunology. 2013. PMID: 23205589 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials